全文获取类型
收费全文 | 11819篇 |
免费 | 765篇 |
国内免费 | 62篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 316篇 |
妇产科学 | 289篇 |
基础医学 | 1726篇 |
口腔科学 | 282篇 |
临床医学 | 1033篇 |
内科学 | 2701篇 |
皮肤病学 | 426篇 |
神经病学 | 1168篇 |
特种医学 | 272篇 |
外科学 | 981篇 |
综合类 | 58篇 |
现状与发展 | 1篇 |
一般理论 | 3篇 |
预防医学 | 1380篇 |
眼科学 | 241篇 |
药学 | 801篇 |
中国医学 | 50篇 |
肿瘤学 | 808篇 |
出版年
2024年 | 11篇 |
2023年 | 141篇 |
2022年 | 273篇 |
2021年 | 529篇 |
2020年 | 270篇 |
2019年 | 447篇 |
2018年 | 539篇 |
2017年 | 328篇 |
2016年 | 313篇 |
2015年 | 387篇 |
2014年 | 536篇 |
2013年 | 652篇 |
2012年 | 1016篇 |
2011年 | 976篇 |
2010年 | 567篇 |
2009年 | 464篇 |
2008年 | 754篇 |
2007年 | 734篇 |
2006年 | 625篇 |
2005年 | 659篇 |
2004年 | 565篇 |
2003年 | 523篇 |
2002年 | 472篇 |
2001年 | 86篇 |
2000年 | 39篇 |
1999年 | 87篇 |
1998年 | 80篇 |
1997年 | 65篇 |
1996年 | 62篇 |
1995年 | 54篇 |
1994年 | 28篇 |
1993年 | 40篇 |
1992年 | 42篇 |
1991年 | 26篇 |
1990年 | 28篇 |
1989年 | 15篇 |
1988年 | 18篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 21篇 |
1983年 | 15篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1974年 | 7篇 |
1972年 | 7篇 |
1970年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
The concept of drug class effect is profoundly rooted in clinical practice. The use of drugs seen as similar in their clinical effects--and therefore interchangeable--is very frequent: two examples of this are the use of beta-blockers in arterial hypertension and angiotensin-converting enzyme (ACE) inhibitors in congestive heart failure. The definition of drug class effect is based on three concepts: a similar chemical structure (for example, the dihydropyridine ring of some calcium channel blockers), a similar mechanism of action (beta-blockers block adrenoreceptors), or similar pharmacological effects (antihypertensives, antianginals, etc.). In this article, we will describe the type of evidence that a cardiologist can use in order to select a specific drug (from within a class). It constitutes a clinical approach, different from the one that might be used by a third party payer (more interested in cost-effectiveness issues) or the pharmaceutical industry (more interested in promoting sales). As usual, the recommendations are based on the strength of scientific evidence. 相似文献
982.
Isabel Bogado Adriana Limansky Emma Sutich Patricia Marchiaro Marta Marzi Juan Putero Alejandro Viale 《Infection control and hospital epidemiology》2002,23(8):447-451
OBJECTIVE: To evaluate clonal dissemination of methicillin-resistant coagulase-negative staphylococci (CNS). SETTING: Neonatal intensive care unit of a 180-bed, university-affiliated general hospital. PATIENTS: Neonates admitted to the neonatal intensive care unit between March 1999 and October 2000, from whom CNS were isolated as a unique pathogen. Patients from other wards from whom epidemiologically unrelated staphylococci strains were obtained served as control-patients. METHODS: Conventional methods were used for phenotypic characterization of CNS. Methicillin resistance was determined by mecA polymerase chain reaction (PCR) amplification. Genotypic characterization was done by random amplification of DNA with degenerated primers (RAPD) and repetitive element sequence-based PCR (rep-PCR). RESULTS: Forty methicillin-resistant CNS isolates obtained from neonates were characterized as Staphylococcus epidermidis (33), S. hominis (5), S. warneri (1), and S. auricularis (1). Both RAPD and rep-PCR indicated the presence of 4 different clones among the 33 S. epidermidis isolates. In turn, the 4 randomly selected, epidemiologically unrelated methicillin-resistant CNS strains obtained from control-patients showed 3 new profiles by RAPD and 2 by rep-PCR, which differed from the corresponding patterns mentioned earlier. Persistence of S. hominis in a neonate could be assessed by both genotypic techniques. CONCLUSIONS: The molecular characterization of the methicillin-resistant CNS studied indicated dissemination of one particular methicillin-resistant CNS clone among the neonates in the ward studied. Although RAPD showed a superior power to discriminate among methicillin-resistant CNS isolates, both RAPD and rep-PCR detected intraspecific and interspecific genomic diversity. 相似文献
983.
Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model
Andressa Bernardi Elizandra Braganhol Eliézer Jäger Fabrício Figueiró Maria Isabel Edelweiss Adriana R. Pohlmann Sílvia S. Guterres Ana M.O. Battastini 《Cancer letters》2009
Multimodal combinations of target agents with radiation and chemotherapy may enhance cancer treatment efficacy; however, despite these treatments, gliomas recur early due to their highly proliferative, infiltrative and invasive behaviors. Nanoparticles of biodegradable polymers for anticancer drug delivery have attracted intensive interest in recent years since they may provide a sustained, controlled and targeted delivery. In the present study, we investigated the effect of indomethacin-loaded nanocapsules in an experimental glioma model. The rats treated with indomethacin-loaded nanocapsules demonstrated a significant reduction in tumor size and half of these animals presented just cells with characteristics of a residual tumor, as shown by immunostaining for nestin. Pathological analyses showed that the treated gliomas presented a significant reduction in the mitotic index and other histological characteristics that indicate a less invasive/proliferative tumor. An important finding of the present study is that indomethacin carried by polymeric nanocapsules achieved higher intracerebral drug concentrations than those of indomethacin in solution. Furthermore, indomethacin achieved a greater concentration in the hemisphere where the glioma was implanted, compared with the contralateral healthy hemisphere. Indomethacin-loaded nanocapsule treatment did not cause characteristics of toxicity and increased the survival of animals. Thus, our results show that polymeric nanocapsules are able to increase the intratumoral bioavailability of indomethacin and reduce the growth of implanted gliomas. Data suggest that indomethacin-loaded nanocapsules could offer new and potentially highly effective strategies for the treatment of malignant gliomas. 相似文献
984.
985.
986.
Isabel Odriozola-Serrano Robert Soliva-Fortuny Olga Martín-Belloso 《Journal of food composition and analysis》2010,23(1):37-43
The effect of different modified atmosphere packaging conditions (2.5 kPa O2 + 7 kPa CO2, 10 kPa O2 + 5 kPa CO2, 21 kPa O2, 60 kPa O2 and 80 kPa O2) on the antioxidant properties of fresh-cut strawberries was investigated. Changes in phenolic acids, flavonoids (anthocyanins and flavonols), vitamin C and antioxidant capacity were analyzed for 21 days at 4 °C. O2, and CO2 package headspace concentrations were also evaluated. The initial quercetin content was maintained for 11–14 days regardless of the initial in-package atmospheres, but then it was dramatically enhanced in the strawberries stored at ≥21 kPa O2. High O2 concentrations inside headspace packages promoted greater losses of phenolic acids (p-coumaric, hydroxybenzoic and ellagic acid) and vitamin C during the storage period compared to low O2 levels. Anthocyanin content increased significantly beyond day 9 in strawberry wedges stored at ≤21 kPa O2, whereas it was almost constant throughout the storage in fresh-cut strawberries at superatmospheric O2 atmospheres. In general, low-O2 and passive atmospheres best maintained the initial antioxidant capacity of fresh-cut strawberries through the cold storage. Therefore, 2.5 kPa O2 + 7 kPa CO2 atmospheres are proposed to prevent oxidation of the main antioxidant compounds in fresh-cut strawberries. 相似文献
987.
988.
Rafael Arráns María Isabel Gallardo Joan Roselló Francisco Sánchez-Doblado 《Radiotherapy and oncology》2005,75(2):224-226
This work presents an improvement to an algorithm for analytical beam weighting optimization where a flexible objective function, which considers 'importance factors' for each anatomical region and 'allowed deviations' from the prescribed dose, is defined. This upgrading allows forcing the mean value of the dose distribution to be the desired value, by using Lagrange multipliers. A real case is presented to show the effect of this change. 相似文献
989.
César P. Ramírez Plaza Manuel A. Cobo Dols Alberto Gómez Portilla Agustín de la Fuente Perucho 《Clinical & translational oncology》2005,7(10):421-431
The median survival in patients with peritoneal carcinomatosis from colorectal adenocarcinoma is, with conventional approaches,
only about six months. Combined treatment consisting of maximum cytoreductive surgery plus intraoperative intraperitoneal
hyperthermic chemotherapy has been shown, albeit in small non-comparative series, to increase disease-free survival and overall
survival, compared with previous series. Further, a randomized trial has demonstrated better results (a median survival of
22.4 months) with cytoreduction plus intraperitoneal chemotherapy compared with conventional chemotherapy. Technical considerations,
infrastructure requirements and possible complications imply specialized centres and staff. Surgery consists of peritonectomy
of affected areas and fulguration of all macroscopic lesions. Intraperitoneal chemotherapy must reach all parts of the peritoneal
cavity and the temperature of the hyperthermic procedure must be maintained between 42–44°C. Three prognostic factors associated
with this procedure are: pathologic tumour grade, peritoneal carcinomatosis index, and cytoreductive surgery grade. 相似文献
990.
Sven Arke Lang Isabel Brecht Christian Moser Aiman Obed David Batt Hans Juergen Schlitt Edward Kenneth Geissler Oliver Stoeltzing 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2008,393(3):333-341
Background and aims Activation of the mitogen-activated protein kinase–extracellular-signal-regulated kinase (ERK) pathways plays an important
role in the progression of hepatocellular carcinoma (HCC). Importantly, Raf kinases are principal effectors within this oncogenic
signaling cascade. We hypothesized that concomitant inhibition of Raf and vascular endothelial growth factor receptor 2 (VEGFR2)
will affect tumor growth and angiogenesis of HCC.
Materials and methods Human HCC cell lines, endothelial cells (EC), and vascular smooth muscle cells (VSMC) were used. For blocking Raf kinase and
VEGFR2, the small molecule inhibitor NVP-AAL881 (Novartis, USA) was used. Activation of signaling intermediates was assessed
by Western blotting, and changes in cell motility were evaluated in migration assays. Effects of NVP-AAL881 on HCC growth
were determined in a subcutaneous tumor model.
Results NVP-AAL881 disrupted activation of ERK and STAT3 in HCC cells and reduced cancer cell motility. In addition, the migration
of ECs and VSMC was also significantly impaired. In ECs, HCC-conditioned media-induced activation of STAT3 was diminished
by NVP-AAL881 treatment. In vivo, NVP-AAL881 significantly reduced tumor growth, CD31-vessel area, and numbers of BrdU-positive
proliferating tumor cells.
Conclusions Combined inhibition of Raf and VEGFR2 disrupts oncogenic signaling and efficiently reduces tumor growth and vascularization
of HCC. Hence, this strategy could prove valuable for therapy of HCC.
German Society of Surgery, Surgical Forum 2008, Best of Abstracts
Sven Arke Lang and Isabel Brecht contributed equally to this work.
These studies were supported, in part, by the German Cancer Aid (Deutsche Krebshilfe, Max-Eder Programm, Bonn, Germany; O.S.),
and a grant from the University of Regensburg, Medical Faculty (ReForM; O.S.; S.A.L.). 相似文献